Expressive

rs11696516 - NFATC2

Magnitude 2.2 · 2 studies on file

Reported associations

  • Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases - Unknown journal (n.d.) · Unknown authors · PubMed 36653479

    ABSTRACT: Little is known about the genetic determinants of medication use in preventing cardiometabolic diseases. Using the Finnish nationwide drug purchase registry with follow-up since 1995, we performed genome-wide association analyses of longitudinal patterns of medication use in hyperlipidemia, hypertension and type 2 diabetes in up to 193,933 individuals (55% women) in the FinnGen study. In meta-analyses of up to 567,671 individuals combining FinnGen with the Estonian Biobank and the UK Biobank, we discovered 333 independent loci (P < 5 × 10-9) associated with medication use. Fine-mapping revealed 494 95% credible sets associated with the total number of medication purchases, changes in medication combinations or treatment discontinuation, including 46 credible sets in 40

  • High Blood Pressure and Intraocular Pressure: A Mendelian Randomization Study - Unknown journal (n.d.) · Unknown authors · PubMed 35762941

    ABSTRACT: Purpose To test for causality with regard to the association between blood pressure (BP) and intraocular pressure (IOP) and glaucoma. Methods Single nucleotide polymorphisms (SNPs) associated with BP were identified in a genome-wide association study (GWAS) meta-analysis of 526,001 participants of European ancestry. These SNPs were used to assess the BP versus IOP relationship in a distinct sample (n = 70,832) whose corneal-compensated IOP (IOPcc) was measured. To evaluate the BP versus primary open-angle glaucoma (POAG) relationship, additional Mendelian randomization (MR) analyses were conducted using published GWAS summary statistics. Results Observational analysis revealed a linear relationship between BP traits and IOPcc, with a +0.28 mm Hg increase in IOPcc per 10-mm Hg inc

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • Cardiovascular risk assessment with healthcare provider Moderate

    rs11696516 associated with elevated diastolic BP increases cardiovascular risk; personalized management recommended

    Discuss genetic risk factors, blood pressure targets, and management strategies

Exercise

  • Regular aerobic exercise for blood pressure management Moderate

    Aerobic exercise reduces blood pressure; genetic predisposition from rs11696516 warrants consistent exercise

    150 minutes moderate intensity aerobic activity per week

Screening

  • Diastolic blood pressure monitoring Moderate

    rs11696516 in NFATC2 is associated with elevated diastolic blood pressure in large GWAS

    Check blood pressure at least annually, more frequently if elevated